BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27123834)

  • 1. The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.
    Mian YA; Zeleznik-Le NJ
    Leuk Res; 2016 Jul; 46():51-60. PubMed ID: 27123834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.
    Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G
    Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for MEIS1 in MLL-fusion gene leukemia.
    Kumar AR; Li Q; Hudson WA; Chen W; Sam T; Yao Q; Lund EA; Wu B; Kowal BJ; Kersey JH
    Blood; 2009 Feb; 113(8):1756-8. PubMed ID: 19109563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.
    Jiang X; Huang H; Li Z; Li Y; Wang X; Gurbuxani S; Chen P; He C; You D; Zhang S; Wang J; Arnovitz S; Elkahloun A; Price C; Hong GM; Ren H; Kunjamma RB; Neilly MB; Matthews JM; Xu M; Larson RA; Le Beau MM; Slany RK; Liu PP; Lu J; Zhang J; He C; Chen J
    Cancer Cell; 2012 Oct; 22(4):524-35. PubMed ID: 23079661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
    Li Z; Huang H; Chen P; He M; Li Y; Arnovitz S; Jiang X; He C; Hyjek E; Zhang J; Zhang Z; Elkahloun A; Cao D; Shen C; Wunderlich M; Wang Y; Neilly MB; Jin J; Wei M; Lu J; Valk PJM; Delwel R; Lowenberg B; Le Beau MM; Vardiman J; Mulloy JC; Zeleznik-Le NJ; Liu PP; Zhang J; Chen J
    Nat Commun; 2012 Feb; 3():688. PubMed ID: 22353710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
    Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG
    Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
    Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
    Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
    Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
    Willer A; Jakobsen JS; Ohlsson E; Rapin N; Waage J; Billing M; Bullinger L; Karlsson S; Porse BT
    Leukemia; 2015 May; 29(5):1018-31. PubMed ID: 25349154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
    Nguyen AT; Taranova O; He J; Zhang Y
    Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia.
    Dou Y; Hess JL
    Int J Hematol; 2008 Jan; 87(1):10-8. PubMed ID: 18224408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of MLL amino terminal sequences with menin is required for transformation.
    Caslini C; Yang Z; El-Osta M; Milne TA; Slany RK; Hess JL
    Cancer Res; 2007 Aug; 67(15):7275-83. PubMed ID: 17671196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation.
    Mamo A; Krosl J; Kroon E; Bijl J; Thompson A; Mayotte N; Girard S; Bisaillon R; Beslu N; Featherstone M; Sauvageau G
    Blood; 2006 Jul; 108(2):622-9. PubMed ID: 16469876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
    Popovic R; Riesbeck LE; Velu CS; Chaubey A; Zhang J; Achille NJ; Erfurth FE; Eaton K; Lu J; Grimes HL; Chen J; Rowley JD; Zeleznik-Le NJ
    Blood; 2009 Apr; 113(14):3314-22. PubMed ID: 19188669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
    Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
    Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.